T. Rowe Price Investment Management
RMD icon

T. Rowe Price Investment Management’s ResMed RMD Stock Holding History

T. Rowe Price Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4
Closed -$1K – 879
2025
Q4 		$1K Sell
4
-4
-50% -$1.02K ﹤0.01% 895
2025
Q3 		$3K Buy
+8
New +$2.19K ﹤0.01% 833

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Investment Management's RMD Position: Q1 2026 in Review

T. Rowe Price Investment Management sold out of ResMed (RMD) in Q1 2026, closing a stake of 4 shares — an estimated $1K sold.

T. Rowe Price Investment Management first reported a position in RMD in Q3 2025 and held it in 2 quarters. The position peaked at $3K in Q3 2025. 940 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • T. Rowe Price Investment Management reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 4 ResMed shares in Q1 2026, an estimated $1K.
  • T. Rowe Price Investment Management first reported a position in ResMed in Q3 2025 and held it in 2 quarters.
  • T. Rowe Price Investment Management's ResMed position peaked at $3K in Q3 2025.
  • 940 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.